Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Walla Walla › NPI 1386895886
Hospital

Providence Health & Services - Washington

Providence Health & Services - Washington was paid $17.35M by Medicaid between Jan 2018 and Dec 2024, across 270 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.

33Billing provider infoPROVIDENCE HEALTH & SERVICES - WASHINGTON
WALLA WALLA, WA 99362
33aNPI1386895886assigned 10/02/2008
28Total paid$17.35M
24GClaims631,195
24DCodes billed270
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#26 of 49
Median peer was paid$20.06M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201899,967$2.72M
201996,469$2.76M
202086,301$2.22M
2021103,009$2.56M
202296,046$2.64M
202382,549$2.33M
2024incomplete66,854$2.12M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 26,965 24,038 $3.22M
96361 Intravenous infusion, hydration; each additional hour 15% 8,849 7,676 $2.57M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 21,356 18,851 $2.01M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.9% 14,286 12,887 $1.19M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.6% 10,199 9,652 $805K
74177 Computed tomography, abdomen and pelvis; with contrast material 4.2% 4,677 4,499 $728K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.9% 6,397 4,172 $685K
70450 Computed tomography, head or brain; without contrast material 3.0% 4,291 4,015 $516K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.4% 6,446 4,966 $421K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.0% 2,231 2,155 $351K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.9% 2,452 2,233 $329K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.8% 1,626 1,606 $308K
258 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.7% 3,894 $288K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.3% 824 $231K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.2% 1,701 $209K
80053 Comprehensive metabolic panel 1.1% 35,587 $198K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.1% 937 $186K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 6,901 $183K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 1,206 $177K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,054 $157K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,012 $153K
59025 Fetal non-stress test <1% 849 $120K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,204 $113K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 259 $110K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 40,238 $96K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,937 $91K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 650 $83K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,984 $78K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 332 $77K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,601 $73K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,132 $63K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 778 $60K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,193 $46K
95800 <1% 182 $46K
71046 Radiologic examination, chest; 2 views <1% 3,239 $40K
93971 <1% 491 $39K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 95 $38K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 789 $36K
84484 <1% 7,914 $35K
76642 <1% 476 $35K
64483 <1% 81 $33K
80048 Basic metabolic panel (calcium, ionized) <1% 6,666 $30K
97113 <1% 796 $29K
84443 Thyroid stimulating hormone (TSH) <1% 5,410 $29K
97535 Self-care/home management training, each 15 minutes <1% 1,443 $25K
G0378 Hospital observation service, per hour <1% 2,067 $24K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 109 $24K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,826 $23K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,618 $23K
73030 <1% 1,687 $23K
76830 Ultrasound, transvaginal <1% 1,004 $23K
83036 Hemoglobin; glycosylated (A1C) <1% 4,962 $22K
93017 <1% 226 $22K
12001 <1% 104 $21K
74018 <1% 1,699 $21K
95806 <1% 39 $21K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,958 $21K
84145 <1% 2,233 $21K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,446 $21K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,345 $20K
87040 <1% 3,236 $20K
83605 <1% 4,979 $19K
80050 General health panel <1% 2,664 $18K
80061 Lipid panel <1% 4,609 $17K
71250 <1% 405 $16K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 688 $15K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,562 $15K
82607 <1% 1,447 $15K
76770 <1% 186 $14K
72125 Computed tomography, cervical spine; without contrast material <1% 1,170 $14K
72100 <1% 1,005 $14K
97162 <1% 399 $14K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 52 $13K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,984 $13K
97161 <1% 331 $13K
73610 <1% 1,203 $13K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,485 $13K
73562 <1% 784 $12K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,827 $12K
71045 Radiologic examination, chest; single view <1% 8,952 $11K
82728 <1% 2,109 $11K
83880 <1% 3,143 $11K
73630 <1% 987 $10K
73130 <1% 1,013 $10K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 384 $9K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13,403 $9K
87186 <1% 3,266 $9K
76801 <1% 187 $9K
85379 <1% 1,852 $9K
73560 <1% 799 $9K
86803 <1% 1,701 $9K
81001 <1% 16,452 $9K
87510 <1% 1,346 $9K
70551 Magnetic resonance imaging, brain; without contrast material <1% 43 $8K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,475 $8K
86140 <1% 2,775 $8K
73110 <1% 559 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,894 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 10,967 $7K
87070 <1% 2,213 $7K
84439 <1% 1,558 $7K
87077 <1% 4,225 $7K
82570 <1% 2,130 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,744 $6K
72141 <1% 71 $6K
87660 <1% 1,346 $6K
73502 <1% 496 $6K
85027 <1% 2,843 $6K
83735 <1% 4,426 $5K
96367 <1% 108 $5K
87480 <1% 1,346 $5K
85651 <1% 2,527 $5K
80143 <1% 1,472 $5K
83540 <1% 1,617 $5K
87631 <1% 270 $5K
84466 <1% 1,355 $4K
J7050 Infusion, normal saline solution, 250 cc <1% 7,659 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,157 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,560 $4K
36415 Collection of venous blood by venipuncture <1% 7,189 $4K
84702 <1% 1,801 $4K
85610 <1% 4,569 $4K
85055 <1% 582 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 882 $4K
87205 <1% 1,824 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 24 $3K
70486 <1% 82 $3K
72040 <1% 199 $3K
10061 <1% 13 $3K
90715 <1% 162 $3K
70498 <1% 52 $3K
83690 <1% 9,716 $3K
82746 <1% 369 $3K
86592 <1% 437 $2K
80179 <1% 1,429 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 85 $2K
73140 <1% 149 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,022 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 13 $2K
70496 <1% 12 $2K
82043 <1% 869 $2K
84156 <1% 806 $2K
93226 <1% 79 $2K
76536 <1% 24 $2K
82550 <1% 778 $2K
81015 <1% 667 $1K
84703 <1% 2,348 $1K
84403 <1% 137 $1K
94010 <1% 39 $1K
72110 <1% 53 $1K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 75 $1K
71271 <1% 17 $1K
81003 <1% 1,838 $1K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 365 $1K
J2704 Injection, propofol, 10 mg <1% 5,266 $1K
87081 <1% 290 $1K
84100 <1% 538 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 107 $1K
84153 <1% 203 $1K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 15 $1K
87505 <1% 36 $968.07
82962 <1% 5,492 $888.67
87340 <1% 348 $880.88
84481 <1% 189 $873.11
93225 <1% 79 $862.39
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,670 $804.45
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 6,722 $735.13
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,434 $686.06
85018 <1% 279 $679.55
A9270 Non-covered item or service <1% 7,683 $662.83
72050 <1% 27 $660.62
86850 <1% 1,070 $607.59
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 504 $585.24
80069 <1% 82 $579.14
73080 <1% 53 $575.97
80076 <1% 108 $559.29
J3490 Unclassified drugs <1% 636 $558.98
82077 <1% 2,287 $548.56
94729 <1% 41 $547.81
86900 <1% 1,568 $536.62
81025 <1% 5,359 $536.08
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 9,847 $467.66
86901 <1% 1,568 $458.97
86706 <1% 90 $438.12
87075 <1% 271 $411.98
85730 <1% 700 $384.37
87506 <1% 20 $367.99
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,806 $339.33
87899 <1% 140 $332.10
83615 <1% 791 $323.23
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 12 $309.62
83970 <1% 17 $294.65
86141 <1% 343 $280.99
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 316 $259.65
86038 <1% 52 $252.73
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 56 $251.83
73590 <1% 28 $237.56
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,929 $211.86
97163 <1% 12 $204.81
87634 <1% 12 $191.70
87427 <1% 88 $190.10
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,500 $184.05
J2550 Injection, promethazine hcl, up to 50 mg <1% 950 $176.26
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,983 $158.71
J1170 Injection, hydromorphone, up to 4 mg <1% 6,035 $147.08
83525 <1% 27 $128.74
90686 <1% 14 $127.54
84550 <1% 61 $123.63
86704 <1% 45 $122.17
82565 <1% 86 $108.74
80164 <1% 14 $102.38
J8540 Dexamethasone, oral, 0.25 mg <1% 1,087 $74.51
87045 <1% 26 $73.68
36591 <1% 209 $72.40
87046 <1% 48 $64.52
96376 <1% 2,379 $61.30
A9585 Injection, gadobutrol, 0.1 ml <1% 1,243 $53.85
86364 <1% 12 $53.47
J3010 Injection, fentanyl citrate, 0.1 mg <1% 5,996 $41.24
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,907 $40.31
86708 <1% 14 $39.82
87015 <1% 26 $36.88
84402 <1% 12 $33.52
88304 <1% 14 $29.08
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 897 $23.80
J2060 Injection, lorazepam, 2 mg <1% 2,646 $22.18
85014 <1% 14 $20.80
86308 <1% 12 $19.61
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,131 $17.91
88342 <1% 100 $15.22
0353U <1% 403 $14.70
J0690 Injection, cefazolin sodium, 500 mg <1% 2,532 $13.80
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 12 $12.20
94760 <1% 1,593 $8.02
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,375 $8.00
82803 <1% 13 $7.54
36600 <1% 12 $3.69
J1790 Injection, droperidol, up to 5 mg <1% 366 $1.45
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 817 $1.30
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 1,713 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 258 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 792 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 217 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 113 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 58 $0.00
0240U 0% 365 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 567 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 58 $0.00
C1769 Guide wire 0% 85 $0.00
J1815 Injection, insulin, per 5 units 0% 141 $0.00
99153 Mod sedat endo service >5yrs 0% 167 $0.00
V2632 Posterior chamber intraocular lens 0% 13 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 12 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 116 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 904 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 492 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 375 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 13 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 16 $0.00
99152 0% 56 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 47 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 89 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 13 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 42 $0.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 0% 135 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 350 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 13 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 35 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 26 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY FOR ENROLLMENT)
Same official

Other billing entities under ANDERSON, DONALD

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.